These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 792404)

  • 1. Concentrations of erythromycin in serum and tonsil: comparison of the estolate and ethyl succinate suspensions.
    Ginsburg CM; McCracken GH; Culbertson MC
    J Pediatr; 1976 Dec; 89(6):1011-3. PubMed ID: 792404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of erythromycin ethyl succinate, stearate and estolate treatments of group A streptococcal infections of the upper respiratory tract.
    Janicki RS; Garnham JC; Worland MC; Grundy WE; Thomas JR
    Clin Pediatr (Phila); 1975 Dec; 14(12):1098-107. PubMed ID: 1104241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate.
    Welling PG; Elliott RL; Pitterle ME; Corrick-West HP; Lyons LL
    J Pharm Sci; 1979 Feb; 68(2):150-5. PubMed ID: 423080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers.
    Bérubé D; Kirouac D; Croteau D; Bergeron MG; Lebel M
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1227-30. PubMed ID: 3142349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcal pharyngitis therapy. A comparison of two erythromycin formulations.
    Derrick CW; Dillon HC
    Am J Dis Child; 1979 Nov; 133(11):1146-8. PubMed ID: 389036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state].
    Potthast H; Schug B; Elze M; Schwerdtle R; Blume H
    Pharmazie; 1995 Jan; 50(1):56-60. PubMed ID: 7886126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate.
    Ginsburg CM; McCracken GH; Steinberg JB; Crow SD; Dildy BF; Lancaster K; Olsen K
    Pediatr Infect Dis; 1982; 1(6):384-7. PubMed ID: 6761656
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythromycin in the aqueous. Comparative concentrations form the estolate and from the base.
    Nolan J; Lyle WH
    Trans Ophthalmol Soc U K (1962); 1976 Jul; 96(2):338-40. PubMed ID: 797069
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacology of erythromycin in infants and children.
    Ginsburg CM
    Pediatr Infect Dis; 1986; 5(1):124-9. PubMed ID: 3753798
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets.
    DiSanto AR; Tserng KY; Chodos DJ; DeSante KA; Albert KS; Wagner JG
    J Clin Pharmacol; 1980 Jul; 20(7):437-43. PubMed ID: 7430412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorometric determination of erythromycin and erythromycin propionate in whole blood or plasma and correlation of results with microbiological assay.
    Tserng KY; Wagner JG
    Anal Chem; 1976 Feb; 48(2):348-53. PubMed ID: 1247163
    [No Abstract]   [Full Text] [Related]  

  • 12. Penetration of erythromycin into tonsillar tissue.
    Falchi M; Teodori F; Carraro A; Cioce C; Scaglione F; Braga PC; Fraschini F
    Curr Med Res Opin; 1985; 9(9):611-5. PubMed ID: 4053675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.
    Patamasucon P; Kaojarern S; Kusmiesz H; Nelson JD
    Antimicrob Agents Chemother; 1981 May; 19(5):736-9. PubMed ID: 6975059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin therapy for group A streptococcal pharyngitis. Results of a comparative study of the estolate and ethylsuccinate formulations.
    Ginsburg CM; McCracken GH; Crow SD; Dildy BR; Morchower G; Steinberg JB; Lancaster K
    Am J Dis Child; 1984 Jun; 138(6):536-9. PubMed ID: 6372437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythromycin and oleandomycin concentration in the body of angina patients taking the preparations orally].
    Liashenko IuI
    Antibiotiki; 1975 Aug; 20(8):721-5. PubMed ID: 1229996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.
    Croteau D; Bergeron MG; LeBel M
    Antimicrob Agents Chemother; 1988 Apr; 32(4):561-5. PubMed ID: 3259856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of an oral erythromycin product.
    Fraser DG
    Am J Hosp Pharm; 1980 Sep; 37(9):1199-205. PubMed ID: 6998290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of blood levels after oral administration of erythromycin and erythromycin estolate.
    GRIFFITH RS; BLACK HR
    Antibiot Chemother (Northfield); 1962 Jun; 12():398-403. PubMed ID: 13901859
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of beta hemolytic streptococcal pharyngitis. Comparison of amoxicillin, erythromycin estolate, and penicillin V.
    Breese BB; Disney FA; Green JL; Talpey WB
    Clin Pediatr (Phila); 1977 May; 16(5):460-3. PubMed ID: 403044
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythromycin therapy for streptococcal pharyngitis.
    Derrick CW; Dillon HC
    Am J Dis Child; 1976 Feb; 130(2):175-8. PubMed ID: 766615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.